Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Biomarkers

TERT marks recurrence of urothelial cancer

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kinde, I. et al. promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res. http://dx.doi.org/10.1158/0008-5472.CAN-13-2498 (2013)

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lokody, I. TERT marks recurrence of urothelial cancer. Nat Rev Cancer 14, 11 (2014). https://doi.org/10.1038/nrc3668

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrc3668

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer